Global Ovarian Cancer Research Consortium
The Global Ovarian Cancer Research Consortium unites four leading organizations across four continents to accelerate lifesaving progress through international research collaboration.
Global Ovarian Cancer Research Consortium
The Global Ovarian Cancer Research Consortium unites four leading organizations across four continents to accelerate lifesaving progress through international research collaboration.
About the Consortium
A Global Effort Sparked by Shared Urgency
The Consortium, formed in 2024, brings together leading ovarian cancer organizations — Ovarian Cancer Research Alliance in the United States, Ovarian Cancer Research Foundation (Australia), Ovarian Cancer Canada, and Ovarian Cancer Action (United Kingdom). Their mission: to combine forces, resources, and determination to accelerate progress where it’s desperately needed. Now, with compute support from Microsoft’s AI for Good Lab, the Consortium is poised to rewrite the future of ovarian cancer care.
Introducing the AI Accelerator Grant
Artificial Intelligence is transforming the field of cancer research—revolutionizing diagnosis, risk prediction, drug development, and personalized treatment. But ovarian cancer has yet to feel the full power of this transformation.
The Consortium’s inaugural initiative, the AI Accelerator Grant, aims to change that. The game-changing $1 million grant, with an additional $1 million in compute support from Microsoft’s AI for Good Lab, will fund an international research team harnessing the power of AI to improve survival outcomes.
This effort represents a bold step forward in ovarian cancer research and a model for future global initiatives.
Microsoft's AI for Good Lab
Microsoft is generously partnering on this grant to donate up to $1 million of in-kind Azure compute credits to the successful project through Microsoft’s AI for Good Lab-partnership with OCRA. Microsoft’s cloud computing power will enable the successful applicants to accelerate progress against ovarian cancer.
New discoveries are needed to find lifesaving treatments for ovarian cancer, a cancer that tragically still has a low survival rate. Equipping leading researchers around the globe with powerful AI tools and computing resources will help accelerate their critical work, hopefully leading to breakthroughs that save women’s lives. Microsoft’s AI for Good Lab is proud to support ovarian cancer research through this grant.
OCRA’s commitment to advancing ovarian cancer research through international collaboration represents hope. Hope that women worldwide will gain the access, resources, and breakthroughs needed to fight ovarian cancer. The global impact of this unified effort is profound.
The CEOs of the four founding organizations attended the 2024 Helene Harris Memorial Trust (HHMT) International Forum on Ovarian Cancer.
We formed the Consortium with one urgent goal: to supercharge breakthroughs in ovarian cancer research by working together in ways never done before. When we pool expertise, data, and determination across continents, we give scientists the tools—and the reach—they need to make transformative progress.
Founding Members
